Market Cap

Co-Diagnostics, Inc. Market Capitalization:

$39.8 Million

USD as of Jan. 1, 2024

business Co-Diagnostics, Inc. Company Profile

Co-Diagnostics, Inc. Main Stock Listing

NASDAQ: CODX

Market Capitalization History of Co-Diagnostics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $207.62 B
Danaher $171.89 B
Siemens Healthineers AG $66.05 B
DexCom, Inc. $46.50 B
IDEXX Laboratories, Inc. $44.72 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Co-Diagnostics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $39.8 M -54.56%
Jan. 1, 2023 $87.5 M -60.14%
Jan. 1, 2022 $219.5 M -44.70%
Jan. 1, 2021 $397.0 M 293.87%
Jan. 1, 2020 $100.8 M 139.71%
Jan. 1, 2019 $42.0 M -53.10%
Jan. 1, 2018 $89.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Co-Diagnostics, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Co-Diagnostics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: CODX

Stock: FSX: C97

Stock: Munich: C97

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.